Historically wound types remain the same over the ages with only a slight exception being the emergence of femoral punctures associated with catheterization procedures. But with the advent of newer technologies the practice of closing those wounds are changed.
These new products are commonly available on hospitals & trauma centers and have wide range of usage area. Among them Hemostat has become a very popular tool to be used as wound closure material with its excellent properties. When applied to a wound, quickly absorbs blood and other body fluids, transforms into a gel to seal the wound with a protective transparent layer, actively aids in stopping bleeding, and creates an environment for wound healing.
Treatment of damaged cardiac tissue in patients with high bleeding tendency can be very challenging. In this category of surgery Hemostat proved to be a very effective with the combination of collagen sponge for the management of a myocardial wound
Topical hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Hemostats for Wound Closure: Drivers and Restraints
Wound closure has become a very frequent clinical practice which is growing very rapidly. The sophisticated procedures ensure rapid cessation of blood loss, prompt closure, strong adhesion of wound edges, tight sealing, reduced scarring, reduced risk of infection and more rapid healing. There is a pool of patients throughout the world which makes the market of this product is very lucrative. As the price is also very reasonable so acceptance of this product is gradually progressing.
On the other hand some reports come which could restrict the growth. Surgical staples are emerging as the most useful tool on this wound closure segment. Also the market of suture which is there traditionally remains constant if not growing to some parts of the world. Few reports also suggested that patients may suffer with irritation, heat inflammation or redness on skin when hemostat are applied, though its not clear the exact reason for these.
As the market is growing and price is low, so tough competitions will prevail in this segment too.
Hemostats for Wound Closure: Segmentation
Global market for wound closure products consist of hemostat are mainly driven the use of Fibrin which is the combination of thrombin & fibrinogen. Also collagen finds it use as hemostat though it still needs the approval of USFDA.
- Thrombin based Hemostats
- Combination Hemostats
- Oxidized Regenerated Cellulose Hemostats
- Gelatin Hemostats
- Collagen based Hemostats
Hemostats for Wound Closure: Overview
With the rapid technological advancement in healthcare industry the Hemostats is expected to grow at a healthy CAGR in the forecasted period (2015-2025).
Hemostats for Wound Closure: Region-wise Outlook
Geographically, the wound closure products market has been segmented into seven major geographical regions which include North America, Eastern Europe, Western Europe, Asia Pacific exclude Japan, Japan & Latin America, Middle east & Africa. North America contribute the most in this market followed by Europe. With the new product approvals, change in regulatory policies encourages, patient acceptance helps the market to grow. Asia Pacific & Japan pose good growth potential too for wound closure products specially Hemostat.
Hemostats for Wound Closure: Key Players
Wound closure product market is highly fragmented with presence of big & small companies. The market leaders in this area are Johnson & Johnson, Covidien, B. Braun, and 3M.
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-827